|
C1ORF163 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78241999999607E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1552999999952E-05 |
| Normal-vs-Stage2 |
1.222040E-01 |
| Normal-vs-Stage3 |
3.9638000000064E-05 |
| Normal-vs-Stage4 |
3.184400E-04 |
| Stage1-vs-Stage2 |
6.214100E-02 |
| Stage1-vs-Stage3 |
9.657400E-01 |
| Stage1-vs-Stage4 |
6.722800E-01 |
| Stage2-vs-Stage3 |
1.130360E-01 |
| Stage2-vs-Stage4 |
9.019600E-02 |
| Stage3-vs-Stage4 |
6.948000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60230999999289E-05 |
| Normal-vs-AfricanAmerican |
1.197010E-03 |
| Normal-vs-Asian |
1.375860E-03 |
| Caucasian-vs-AfricanAmerican |
9.041200E-01 |
| Caucasian-vs-Asian |
8.718800E-01 |
| AfricanAmerican-vs-Asian |
9.736400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55290000003472E-06 |
| Normal-vs-Female |
1.186670E-04 |
| Male-vs-Female |
6.023600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.74869999999872E-05 |
| Normal-vs-Age(41-60Yrs) |
2.06899999999344E-05 |
| Normal-vs-Age(61-80Yrs) |
2.062400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.455830E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.866000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.679800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.046800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.402200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.680200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.992600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.588400E-01 |
| Classical-VS-Follicular |
7.932400E-01 |
| Classical-VS-Other |
1.151410E-01 |
| Classical-VS-Normal |
3.84629999999886E-05 |
| Tall-VS-Follicular |
8.161200E-01 |
| Tall-VS-Other |
3.550400E-02 |
| Tall-VS-Normal |
7.762100E-03 |
| Follicular-VS-Other |
2.044400E-01 |
| Follicular-VS-Normal |
6.615900E-03 |
| Other-VS-Normal |
5.376400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.571650E-04 |
| Normal-vs-N1 |
8.20040000000244E-05 |
| N0-vs-N1 |
1.409370E-01 |
|
|
